Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan clearance in peritoneal dialysis patients
ChiCTR2200055924Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sacubitril + valsartan in chronic kidney disease (CKD), sponsored by West China Hospital of Sichuan University. Primary endpoints: Plasma valsartan concentration, Plasma sacubitril concentration and 7 more. Started Jan 2022; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2200055924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055924.